📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Evaluating the Cardiovascular Impact of Genetically Proxied PCSK9 and HMGCR Inhibition in East Asian and European Populations: A Drug-Target Mendelian Randomization Study. (2024)

First Author: Rosoff DB

Attributed to: BUD23 drives system-wide adaptations to energy metabolism funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1161/circgen.122.004224

PubMed Identifier: 38258565

Publication URI: http://europepmc.org/abstract/MED/38258565

Type: Journal Article/Review

Volume: 17

Parent Publication: Circulation. Genomic and precision medicine

Issue: 1

ISSN: 2574-8300